ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MREO announcements Mereo Biopharma Group Plc announcements and dividends declared NASDAQ

Mereo Biopharma Group Plc Complete list of announcements declared & dividend announcements by Mereo Biopharma Group Plc MREO

Mereo Biopharma Group Plc MREO listed on NASDAQ and deals in N A N A

Announcements and dividends declared by Mereo Biopharma Group Plc MREO

Needham Reiterates Mereo Biopharma Group Plc - ADR (MREO) Buy Recommendation
Fintel reports that on May 26, 2023, Needham reiterated coverage of Mereo Biopharma Group Plc - ADR (NASDAQ:MREO) with a Buy recommendation.
Announcement as on 27 May 2023

Mereo BioPharma Announces Go-forward Operating Plan; To Cut Up To 40% Jobs
(RTTNews) - UK's Mereo BioPharma Group plc (MREO) announced Tuesday its go-forward operating plan, with a targeted reduction in the employee base of up to 40% and a significant reduction in other costs.
Announcement as on 18 October 2022

Mereo BioPharma (MREO) Up as AstraZeneca Reportedly Eyes Buyout
Shares of small-biotech Mereo BioPharma MREO surged 62.5% on Jun 17, following a report issued by the Times, which stated that AstraZeneca AZN is interested in acquiring the company. Mereo BioPharma is a U.K.-based pharmaceutical company focused on develop
Announcement as on 20 June 2022

Mereo BioPharma (MREO) Up as AstraZeneca Reportedly Eyes Buyout
Shares of small-biotech Mereo BioPharma MREO surged 62.5% on Jun 17, following a report issued by the Times, which stated that AstraZeneca AZN is interested in acquiring the company. Mereo BioPharma is a U.K.-based pharmaceutical company focused on develop
Announcement as on 20 June 2022

AstraZeneca weighing bid for Mereo BioPharma: report
AstraZeneca is considering a bid for London-based, U.S.-listed biotech Mereo BioPharma , The Times reported without attribution. AstraZeneca already is a partner of Mereo, and the report said it may face competition from another of the cancer and rare di
Announcement as on 17 June 2022

Announcements by Mereo Biopharma Group Plc first page | Next page |

MREO Mereo Biopharma Group Plc current price & indicator signals

Moving Averages for Mereo Biopharma Group Plc

  • 5Day Average: 1.93
  • 12Day Average: 1.86
  • 20Day Average: 1.84
  • 50Day Average: 1.93
  • 100Day Average: 1.83
  • 150Day Average: 2.04
  • 200Day Average: 2.12

MREO Indicators & signals

Indicator MACD (12,26,9)

1.9, 1.88, -0.01
Indicator MACD is in positive zone

Indicator ADX (14)

6.67, 53.33, 46.67
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MREO Mereo Biopharma Group Plc are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 2.07 2.00 to 2.10 1.47% 0.62 times
04 Thu Dec 2025 2.04 1.90 to 2.06 4.08% 1 times
03 Wed Dec 2025 1.96 1.74 to 2.18 12% 4.81 times
02 Tue Dec 2025 1.75 1.75 to 1.85 -4.89% 0.45 times
01 Mon Dec 2025 1.84 1.76 to 1.86 -1.6% 0.83 times
28 Fri Nov 2025 1.87 1.81 to 1.89 1.63% 0.25 times
26 Wed Nov 2025 1.84 1.77 to 1.87 2.79% 0.51 times
25 Tue Nov 2025 1.79 1.75 to 1.83 0% 0.61 times
24 Mon Nov 2025 1.79 1.77 to 1.87 -0.56% 0.6 times
21 Fri Nov 2025 1.80 1.76 to 1.82 0.56% 0.41 times
20 Thu Nov 2025 1.79 1.75 to 1.88 -1.1% 0.54 times
19 Wed Nov 2025 1.81 1.80 to 1.90 -0.55% 0.62 times

Videos related to: MREO announcements Mereo Biopharma Group Plc announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

MREO announcements Mereo Biopharma Group Plc announcements and dividends declared NASDAQ

 

Back to top